These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21975240)

  • 1. [Paraoxonase: its multiple functions and pharmacological regulation].
    Fridman O; Fuchs AG; Porcile R; Morales AV; Gariglio LO
    Arch Cardiol Mex; 2011; 81(3):251-60. PubMed ID: 21975240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The growing importance of PON1 in cardiovascular health: a review.
    Macharia M; Hassan MS; Blackhurst D; Erasmus RT; Matsha TE
    J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):443-53. PubMed ID: 22673025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.
    Jakubowski H
    Adv Exp Med Biol; 2010; 660():113-27. PubMed ID: 20221875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase.
    Otocka-Kmiecik A; Orłowska-Majdak M
    Postepy Hig Med Dosw (Online); 2009 Dec; 63():668-77. PubMed ID: 20097953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M; Karry R; Aviram M
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase 1 and homocysteine metabolism.
    Perła-Kaján J; Jakubowski H
    Amino Acids; 2012 Oct; 43(4):1405-17. PubMed ID: 22643843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paraoxonase--important enzyme of the lipid metabolism and potential ally in the antiatherosclerotic treatment].
    Sapian-Raczkowska B; Rabczyński M; Adamiec R
    Pol Merkur Lekarski; 2010 Nov; 29(173):325-7. PubMed ID: 21268919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraoxonases: metabolic role and pharmacological projection.
    Moya C; Máñez S
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):349-359. PubMed ID: 29404699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase 1 protects against protein N-homocysteinylation in humans.
    Perla-Kaján J; Jakubowski H
    FASEB J; 2010 Mar; 24(3):931-6. PubMed ID: 19880629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL--associated paraoxonase 1 (PON1) and dietary antioxidants attenuate lipoprotein oxidation, macrophage foam cells formation and atherosclerosis development.
    Aviram M
    Pathophysiol Haemost Thromb; 2006; 35(1-2):146-51. PubMed ID: 16855361
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1.
    Deakin SP; James RW
    Clin Sci (Lond); 2004 Nov; 107(5):435-47. PubMed ID: 15265000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.
    Ferretti G; Bacchetti T; Marotti E; Curatola G
    Metabolism; 2003 Feb; 52(2):146-51. PubMed ID: 12601623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
    Li C; Gu Q
    Nephrology (Carlton); 2009 Aug; 14(5):514-20. PubMed ID: 19207863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The paraoxonase gene family and atherosclerosis.
    Ng CJ; Shih DM; Hama SY; Villa N; Navab M; Reddy ST
    Free Radic Biol Med; 2005 Jan; 38(2):153-63. PubMed ID: 15607899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional High-density Lipoprotein: The Role of Myeloperoxidase and Paraoxonase-1.
    Bacchetti T; Ferretti G; Carbone F; Ministrini S; Montecucco F; Jamialahmadi T; Sahebkar A
    Curr Med Chem; 2021; 28(14):2842-2850. PubMed ID: 32674726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice.
    She ZG; Zheng W; Wei YS; Chen HZ; Wang AB; Li HL; Liu G; Zhang R; Liu JJ; Stallcup WB; Zhou Z; Liu DP; Liang CC
    Circ Res; 2009 May; 104(10):1160-8. PubMed ID: 19359600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in paraoxonase-1 activity and atherosclerosis.
    Soran H; Younis NN; Charlton-Menys V; Durrington P
    Curr Opin Lipidol; 2009 Aug; 20(4):265-74. PubMed ID: 19550323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.